ADAPTIMMUNE THERAPEUTICS PLC's ticker is and the CUSIP is 00653A907. A total of 2 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 700 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 700 | -22.2% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 900 | -35.7% | 0.00% | – |
| Q4 2022 | $2 | -100.0% | 1,400 | -76.3% | 0.00% | – |
| Q2 2022 | $10,000 | +25.0% | 5,900 | +40.5% | 0.00% | – |
| Q1 2022 | $8,000 | -50.0% | 4,200 | -2.3% | 0.00% | – |
| Q4 2021 | $16,000 | -84.5% | 4,300 | -81.9% | 0.00% | – |
| Q3 2021 | $103,000 | +2.0% | 23,800 | 0.0% | 0.00% | – |
| Q2 2021 | $101,000 | +152.5% | 23,800 | +31215.8% | 0.00% | – |
| Q1 2021 | $40,000 | -51.2% | 76 | -50.3% | 0.00% | – |
| Q4 2020 | $82,000 | +1540.0% | 153 | +2085.7% | 0.00% | – |
| Q3 2020 | $5,000 | -98.0% | 7 | -97.2% | 0.00% | – |
| Q2 2020 | $247,000 | +24600.0% | 247 | +4840.0% | 0.00% | – |
| Q1 2020 | $1,000 | -83.3% | 5 | -68.8% | 0.00% | – |
| Q1 2019 | $6,000 | +20.0% | 16 | +60.0% | 0.00% | – |
| Q4 2018 | $5,000 | -64.3% | 10 | -16.7% | 0.00% | – |
| Q2 2018 | $14,000 | +1300.0% | 12 | +100.0% | 0.00% | – |
| Q1 2018 | $1,000 | -66.7% | 6 | -40.0% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 50,000 | $54,000 | 0.00% |